Abstract #1104
Validation of anti-VEGF Therapy in a Radiation Necrosis Mouse Model
Carlos J Perez-Torres 1 , Liya Yuan 2 , Robert E Schmidt 3 , Keith M Rich 2 , Robert E Drzymala 4 , Joseph JH Ackerman 1,5 , and Joel R Garbow 1
1
Radiology, Washington University, Saint
Louis, MO, United States,
2
Neurosurgey,
Washington University, Saint Louis, MO, United States,
3
Neuropathology,
Washington University, Saint Louis, MO, United States,
4
Radiation
Oncology, Washington University, Saint Louis, MO, United
States,
5
Chemistry,
Washington University, Saint Louis, MO, United States
The use of anti-VEGF antibodies represents a new
treatment approach for radiation necrosis. We present a
timeline of VEGF expression and test the effectiveness
and specificity of anti-VEGF antibody treatment in our
mouse model of radiation necrosis. While the anti-VEGF
antibody treatment has an effect on the extent of
injury, it does not reduce VEGF expression. The
persistence of VEGF could lead to the recurrence of
injury once treatment is stopped.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.